115 related articles for article (PubMed ID: 16721385)
41. Genomic abnormalities in chronic lymphocytic leukemia influence gene expression by a gene dosage effect.
Dickinson JD; Joshi A; Iqbal J; Sanger W; Bierman PJ; Joshi SS
Int J Mol Med; 2006 May; 17(5):769-78. PubMed ID: 16596259
[TBL] [Abstract][Full Text] [Related]
42. High-resolution genomic profiling of adult and pediatric core-binding factor acute myeloid leukemia reveals new recurrent genomic alterations.
Kühn MW; Radtke I; Bullinger L; Goorha S; Cheng J; Edelmann J; Gohlke J; Su X; Paschka P; Pounds S; Krauter J; Ganser A; Quessar A; Ribeiro R; Gaidzik VI; Shurtleff S; Krönke J; Holzmann K; Ma J; Schlenk RF; Rubnitz JE; Döhner K; Döhner H; Downing JR
Blood; 2012 Mar; 119(10):e67-75. PubMed ID: 22234698
[TBL] [Abstract][Full Text] [Related]
43. Pattern robustness of diagnostic gene expression signatures in leukemia.
Kohlmann A; Schoch C; Dugas M; Rauhut S; Weninger F; Schnittger S; Kern W; Haferlach T
Genes Chromosomes Cancer; 2005 Mar; 42(3):299-307. PubMed ID: 15609343
[TBL] [Abstract][Full Text] [Related]
44. Genomic assessment of pediatric acute leukemia.
Mullighan CG; Flotho C; Downing JR
Cancer J; 2005; 11(4):268-82. PubMed ID: 16197717
[TBL] [Abstract][Full Text] [Related]
45. Advances in the development of animal models of myeloid leukemias.
Guryanova OA; Levine RL
Semin Hematol; 2013 Apr; 50(2):145-55. PubMed ID: 24216171
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA expression in acute myeloid leukemia.
Marcucci G; Radmacher MD; Mrózek K; Bloomfield CD
Curr Hematol Malig Rep; 2009 Apr; 4(2):83-8. PubMed ID: 20425419
[TBL] [Abstract][Full Text] [Related]
47. Genetic profile of acute myeloid leukemia.
Mecucci C; Rosati R; Starza RL
Rev Clin Exp Hematol; 2002 Mar; 6(1):3-25; discussion 86-7. PubMed ID: 12060481
[TBL] [Abstract][Full Text] [Related]
48. Use of single nucleotide polymorphism array technology to improve the identification of chromosomal lesions in leukemia.
Iacobucci I; Lonetti A; Papayannidis C; Martinelli G
Curr Cancer Drug Targets; 2013 Sep; 13(7):791-810. PubMed ID: 23941516
[TBL] [Abstract][Full Text] [Related]
49. Cluster-Rasch models for microarray gene expression data.
Li H; Hong F
Genome Biol; 2001; 2(8):RESEARCH0031. PubMed ID: 11532215
[TBL] [Abstract][Full Text] [Related]
50. Induction in myeloid leukemic cells of genes that are expressed in different normal tissues.
Lotem J; Benjamin H; Netanely D; Domany E; Sachs L
Proc Natl Acad Sci U S A; 2004 Nov; 101(45):16022-7. PubMed ID: 15505217
[TBL] [Abstract][Full Text] [Related]
51. An efficient and robust statistical modeling approach to discover differentially expressed genes using genomic expression profiles.
Thomas JG; Olson JM; Tapscott SJ; Zhao LP
Genome Res; 2001 Jul; 11(7):1227-36. PubMed ID: 11435405
[TBL] [Abstract][Full Text] [Related]
52. A gene expression profile associated with relapse of cytogenetically normal acute myeloid leukemia is enriched for leukemia stem cell genes.
Hackl H; Steinleitner K; Lind K; Hofer S; Tosic N; Pavlovic S; Suvajdzic N; Sill H; Wieser R
Leuk Lymphoma; 2015 Apr; 56(4):1126-8. PubMed ID: 25030037
[No Abstract] [Full Text] [Related]
53. Gene expression profiling as a diagnostic tool in acute myeloid leukemia.
Kern W; Kohlmann A; Schnittger S; Hiddemann W; Schoch C; Haferlach T
Am J Pharmacogenomics; 2004; 4(4):225-37. PubMed ID: 15287816
[TBL] [Abstract][Full Text] [Related]
54. Genomic approaches to the pathogenesis of hematologic malignancy.
Golub TR
Curr Opin Hematol; 2001 Jul; 8(4):252-61. PubMed ID: 11561164
[TBL] [Abstract][Full Text] [Related]
55. New data on robustness of gene expression signatures in leukemia: comparison of three distinct total RNA preparation procedures.
Campo Dell'Orto M; Zangrando A; Trentin L; Li R; Liu WM; te Kronnie G; Basso G; Kohlmann A
BMC Genomics; 2007 Jun; 8():188. PubMed ID: 17587440
[TBL] [Abstract][Full Text] [Related]
56. Identification of a tumor suppressor network in T-cell leukemia.
Nagel S; Pommerenke C; Meyer C; Kaufmann M; MacLeod RAF; Drexler HG
Leuk Lymphoma; 2017 Sep; 58(9):2196–2207. PubMed ID: 28142295
[TBL] [Abstract][Full Text] [Related]
57. Primer on medical genomics. Part III: Microarray experiments and data analysis.
Tefferi A; Bolander ME; Ansell SM; Wieben ED; Spelsberg TC
Mayo Clin Proc; 2002 Sep; 77(9):927-40. PubMed ID: 12233926
[TBL] [Abstract][Full Text] [Related]
58. Transcriptional profiling of hematologic malignancies with a low-density DNA microarray.
Alvarez P; Sáenz P; Arteta D; Martínez A; Pocoví M; Simón L; Giraldo P
Clin Chem; 2007 Feb; 53(2):259-67. PubMed ID: 17185367
[TBL] [Abstract][Full Text] [Related]
59. Comprehensive genomic characterization of five canine lymphoid tumor cell lines.
Roode SC; Rotroff D; Richards KL; Moore P; Motsinger-Reif A; Okamura Y; Mizuno T; Tsujimoto H; Suter SE; Breen M
BMC Vet Res; 2016 Sep; 12():207. PubMed ID: 27639374
[TBL] [Abstract][Full Text] [Related]
60. Comprehensive cytogenetic and molecular genetic characterization of the TI-1 acute myeloid leukemia cell line reveals cross-contamination with K-562 cell line.
Rush LJ; Heinonen K; Mrózek K; Wolf BJ; Abdel-Rahman M; Szymanska J; Peltomäki P; Kapadia F; Bloomfield CD; Caligiuri MA; Plass C
Blood; 2002 Mar; 99(5):1874-6. PubMed ID: 11871388
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
